Carregant...

Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

Advanced stage leiomyosarcoma (LMS) is incurable with current systemic antitumor therapies. Therefore, there is clinical interest in exploring novel therapeutic regimens to treat LMS. We reviewed the medical records of 75 consecutive patients with histologically confirmed metastatic LMS, who had bee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Wang, Zhijie, Shi, Naiyi, Naing, Aung, Janku, Filip, Subbiah, Vivek, Araujo, Dejka M., Patel, Shreyaskumar R., Ludwig, Joseph A., Ramondetta, Lois M., Levenback, Charles F., Ramirez, Pedro T., Piha‐Paul, Sarina A., Hong, David, Karp, Daniel D., Tsimberidou, Apostolia M., Meric‐Bernstam, Funda, Fu, Siqing
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224847/
https://ncbi.nlm.nih.gov/pubmed/27882721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.956
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!